EP Patent

EP3424932A1 — Boronophthalides for therapeutic use

Assigned to Anacor Pharmaceuticals LLC · Expires 2019-01-09 · 7y expired

What this patent protects

This invention relates to the therapeutic administration of a compound of formula (IIb): wherein R 7b is a member selected from H, methyl, ethyl and phenyl; R 10b is a member selected from H, OH, NH 2 , SH, halogen, substituted or unsubstituted phenoxy, substituted or u…

USPTO Abstract

This invention relates to the therapeutic administration of a compound of formula (IIb): wherein R 7b is a member selected from H, methyl, ethyl and phenyl; R 10b is a member selected from H, OH, NH 2 , SH, halogen, substituted or unsubstituted phenoxy, substituted or unsubstituted phenylalkyloxy, substituted or unsubstituted phenylthio and substituted or unsubstituted phenylalkylthio; and R 11b is a member selected from H, OH, NH 2 , SH, methyl, substituted or unsubstituted phenoxy, substituted or unsubstituted phenylalkyloxy, substituted or unsubstituted phenylthio and substituted or unsubstituted phenylalkylthio wherein the term "alkyl" is a C 1 -C 10 alkyl group; and to pharmaceutical formulations of such compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP3424932A1
Jurisdiction
EP
Classification
—
Expires
2019-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Anacor Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.